Salarius Pharmaceuticals Adds Seattle Cancer Care Alliance and Oregon Health & Sciences as Clinical Sites for its Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas

Author's Avatar
Aug 04, 2022

Clinical Trial Now Expands to Fifteen U.S. Trial Sites